{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 11, "transaction_limit": 160, "filters": {"q": "", "ticker": "HRTX", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 11, "acquisition_count": 4, "disposal_count": 7, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 2385.84, "disposal_value_label": "$2.4K", "net_value": -2385.84, "net_value_label": "$-2.4K", "flow_tone": "negative", "largest_value_label": "$1.4K", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 11, "value": "2385.8400", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$2.4K"}], "days": [{"transaction_date": "2026-06-16", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 37.5}, {"transaction_date": "2026-07-19", "acquisitions": 3, "disposals": 5, "total": 8, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 7, "acquisition_share": 36.4, "disposal_share": 63.6}}, "company_flows": [{"symbol": "HRTX", "name": "Heron Therapeuti", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-19", "acquisitions": 0, "disposals": 7, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2385.84, "disposed_value_label": "$2.4K", "net_value": -2385.84, "net_value_label": "$-2.4K", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}], "company_overview": [{"symbol": "HRTX", "name": "Heron Therapeuti", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-19", "filings": 11, "acquisitions": 4, "disposals": 7, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 2385.84, "disposed_value_label": "$2.4K", "net_value": -2385.84, "net_value_label": "$-2.4K", "acquisition_share": 36.4, "disposal_share": 63.6, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}], "transactions": [{"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "COLLARD, CRAIG A", "executive_title": "Director, Chief Executive Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 13797.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.911329+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3874.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.918513+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3874.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-29T22:10:41.923633+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1101.0, "share_price": 0.47, "transaction_value": 517.47, "fetched_at": "2026-07-29T22:10:41.916407+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1101.0, "share_price": 0.47, "transaction_value": 517.47, "fetched_at": "2026-07-29T22:10:41.922211+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "COLLARD, CRAIG A", "executive_title": "Director, Chief Executive Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 13797.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.925340+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3874.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.914518+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-19", "executive": "FORBES, WILLIAM P", "executive_title": "EVP, Chief Development Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 3874.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-29T22:10:41.920401+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 12500.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-14T10:51:01.093099+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3555.0, "share_price": 0.38, "transaction_value": 1350.9, "fetched_at": "2026-07-14T10:51:01.085165+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}, {"symbol": "HRTX", "name": "Heron Therapeuti", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-16", "executive": "DUARTE, IRA", "executive_title": "EVP, Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 12500.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T10:51:01.096050+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/hrtx/", "research_links": {"chart": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/", "report": "/terminal/1c611df5-7009-405a-a224-8b2fa7373100/report/", "factor": "/factors/ticker/1c611df5-7009-405a-a224-8b2fa7373100/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}